An Analysis Finds Shingrix is Highly Effective for Preventing Shingles in Seniors
A real-world analysis shows Shingrix effectively prevents shingles in adults over the age of 65, including immunocompromised people. Two doses provide better protection than one.
Shingles is a viral infection that occurs when the varicella-zoster virus (VZV), the same virus that causes chickenpox, reactivates in their body. Although anyone can get shingles, it is more common in adults over the age of 50, according to the CDC.
It presents as a rash, with painful blisters across the chest, abdomen, or face. Between 5% and 30% of patients with shingles experience post-herpetic neuralgia (PHN), a long-lasting nerve pain that can last weeks or months.
Shingrix is a recombinant zoster vaccine (RZV) that is manufactured by GSK.
Shingrix is effective in preventing shingles in adults over the age of 65, including immunocompromised adults, with two doses being more effective than one.
Author's summary: Shingrix prevents shingles in seniors.